SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning the Sale of Sagent Pharmaceuticals, Inc. to Nichi-Iko Pharmaceutical Co., Ltd. for $21.75 Per Share is Fair to Shareholders -- SGNT
NEW YORK, July 13, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Sagent Pharmaceuticals, Inc. ("Sagent") (NASDAQ: SGNT) stock prior to July 11, 2016.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Sagent to Nichi-Iko Pharmaceutical Co., Ltd. for $21.75 per share. To learn more about the action and your rights, go to:
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP Joseph E. Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com